25 June 2020 - The European Union is one of the U.S. Food and Drug Administration’s most important collaborators in tackling public heath challenges. 

The FDA and the European Commission  and its European Medicines Agency have long leveraged each other’s expertise and experience to promote the safety, effectiveness, and quality of medical products to advance the health of our citizens. 

Now, our work, built together over more than a decade, has paved the way for a multitude of critical collaborations on many scientific and regulatory fronts as part of our COVID-19 response.

Read FDA Voices article